U.S. Genome Editing Market 2024 Supply-Demand, Production Cost and Share Analysis
U.S. Genome Editing Industry The U.S. genome editing market size was estimated at USD 3.49 billion in 2023 and is expected to grow at a CAGR of 16.5% from 2024 to 2030. The growth in the genome editing market is driven by rising demand for synthetic genes, the application of CRISPR technology, and government funding. The expansion is further fueled by the production of genetically modified crops, genomics projects, and advancements in research and development. Innovative gene editing methods have advanced gene therapy and molecular biology significantly. The availability of user-friendly gene therapy systems and the potential for rapid genome-wide analyses also contribute to the market growth. The U.S. accounted for over 43.9% of the global genome editing market in 2023. The advent of innovative technologies enabling easy editing of genomic DNA has unlocked a transformative period in therapeutic development. Genome editing technology has the potential to take precision medicine t...